Acanthopanax for Acute Ischemic Stroke | Zendy

Weizheng Li | Zendy; Ming Liu | Zendy; Shejun Feng | Zendy; Bo Wu | Zendy; ShiHong Zhang | Zendy; Weimin Yang | Zendy; Guan Jian Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acanthopanax for Acute Ischemic Stroke

Author(s) -

Weizheng Li,

Ming Liu,

Shejun Feng,

Bo Wu,

ShiHong Zhang,

Weimin Yang,

Guan Jian Liu

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.593855

Subject(s) - medicine , stroke (engine) , ischemic stroke , cardiology , acute stroke , ischemia , tissue plasminogen activator , mechanical engineering , engineering

Graeme J. Hankey MD, FRCP, FRACP Section Editor: Acute ischemic stroke is a common cause of death and disability. Acanthopanax is widely used in the treatment of acute ischemic stroke in China, and a number of studies on Acanthopanax for acute ischemic stroke were published in Chinese journals. However, whether there is adequate randomized evidence for its efficacy is unclear. ObjectivesThe objective of this review was to assess the efficacy and safety of Acanthopanax in patients with acute ischemic stroke. Search StrategyWe searched the Cochrane Stroke Group Trials Register (last searched January 2008), the Chinese Stroke Trials Register (last searched March 2008), and the Trials Register of the Cochrane Complementary Medicine Field (last searched January 2008). In addition, we searched the Cochrane Central Register of Controlled Trials (CENTRAL; The Cochrane Library Issue 1, 2008), MEDLINE (1966 to March 2008), …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research